Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Comprehensive wet-bench and bioinformatics workflow for complex microbiota using Oxford Nanopore Technologies

PROVIDER: PRJEB47459 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	ERR6688250.fastq.gz	Fastqsanger.gz
	ERR6688260.fastq.gz	Fastqsanger.gz
	ERR6688270.fastq.gz	Fastqsanger.gz
	ERR6688280.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 218

Similar Datasets

Short and long read sequencing of human mammary epithelial MCF10a-Snail-ER cells after Epithelial-to-Mesenchymal Transition initiation

Project description:We cultured MCF10a-Snail-ER cells and induced EMT initiation with tamoxifen. A matched sequencing of their PolyA RNA was performed, using Illumina and direct RNA Oxford Nanopore sequencing technologies. Both generated datasets supported the development of hybrid bioinformatics tools.

2021-09-09 | GSE126638 | GEO

scNanoATAC-seq: Long-read Single-cell ATAC-seq by Oxford Nanopore Technologies Sequencing [DATASet2: bulkATAC-seq]

Project description:We present scNanoATAC-seq (Single-cell Assay for Transposase Accessible Chromatin by Oxford Nanopore Technologies Sequencing), an effective method for simultaneous detection of chromatin accessibility and genetic variation. Long fragments (about 4-5Kb) of single-cell ATAC-seq library were enriched and sequenced by Oxford Nanopore Technologies platform. Ends of long ATAC-seq fragments are regarded as chromatin accessibility signal in downstream analysis.

2022-09-07 | GSE194023 | GEO

scNanoATAC-seq: Long-read Single-cell ATAC-seq by Oxford Nanopore Technologies Sequencing [DataSet1: scNanoATAC-seq]

2022-09-07 | GSE194022 | GEO

Defining Giardia lamblia cleavage sites

Project description:3'-end sequencing and Oxford Nanopore Technologies long-read sequencing of trophozoite RNA to define mRNA cleavage sites

2022-03-09 | GSE168675 | GEO

Detailed analysis of the murine-aged brain transcriptome [ONT]

Project description:In this work, we collected and analyzed two cohorts of young-adult and aged-adult mice brain mRNAs and determined their levels using second- (illumina) and third-generation (Oxford Nanopore) sequencing technologies. We report a transcriptome-wide study of differential transcript usage during brain aging. In addition, we provide the community with a large resource of whole brain transcriptomes and comprehensive analyses that identify widespread diversity of mRNAs during aging.

2024-03-13 | GSE233836 | GEO

Detailed analysis of the murine-aged brain transcriptome [Illumina]

2024-03-13 | GSE233835 | GEO

RNA-seq of human liver cancer cell line SNU-398 treated with a novel sulfane sulfur donor (PSCP) against untreated controls

Project description:This study elucidates the molecular mechanisms underlying the antitumor effects of a novel sulfane sulfur donor compound on hepatocellular carcinoma (HCC) cells using RNA sequencing analysis. While sulfane sulfur has emerged as a crucial signaling molecule with therapeutic potential in cancer treatment, its precise mechanisms of action remain to be fully elucidated. We synthesized a novel sulfane sulfur donor (persulfided cysteine precursor, PSCP) that exhibits potent inhibitory effects on HCC cells. Through comprehensive RNA-seq analysis of PSCP-treated HCC cells versus controls, we uncovered a complex regulatory mechanism involving mitochondrial damage, AMPK activation, and p53-mediated cellular responses, including both proliferation inhibition and apoptosis induction. Our findings demonstrate that PSCP exerts its anti-HCC effects through a mitochondrial damage-AMPK-p53 signaling cascade, with p53 serving as a key mediator that both suppresses cell proliferation and promotes apoptosis. These results provide novel insights into the antitumor mechanisms of sulfane sulfur compounds and highlight their therapeutic potential in HCC treatment.  Treatment group: SNU398 HCC cells treated with 200 μM PSCP for 24 hours  Control group: SNU398 cells treated with vehicle control  Three-four biological replicates per group  mRNA extraction using TRIzol reagent (Invitrogen, MD, USA)  Sequencing performed by Biomarker Technologies (Guangzhou, China)  Sequencing platform: Oxford Nanopore Technologies (Oxford, UK)  Data analysis conducted using BMK_Cloud platform

2025-01-31 | E-MTAB-14578 | biostudies-arrayexpress

Long-read Nanopore sequencing of synthetic "sequin" controls

Project description:Purpose: To generate a reference long-read transcriptomic data set for use in developing new analysis pipelines and comparing their performance with existing methods. Synthetic “sequin” RNA standards (Hardwick et al. 2016) were sequenced using the Oxford Nanopore Technologies (ONT) GridION platform.

2020-06-18 | GSE151984 | GEO

Klebsiella pneumoniae

Project description:Texas Catheter Biofilm Isolates Sequencing Using Oxford Nanopore Technologies

| PRJNA472804 | ENA

Long-read transcriptomics of a diverse human cohort reveals widespread ancestry bias in gene annotation

Project description:Understanding gene expression diversity across human populations is essential for accurate genome annotation and disease interpretation. However, existing annotations are primarily based on European-derived transcriptomic data, potentially limiting their applicability to other populations. This study aims to assess population-specific transcript diversity and its impact on gene annotation. To achieve this, we performed long-read RNA sequencing on lymphoblastoid cell lines from 43 individuals across eight globally diverse populations. Our workflow included RNA extraction, cDNA synthesis, and sequencing using Oxford Nanopore long-read technology, followed by transcript assembly and comparison with existing gene annotations. We also integrated novel transcripts into reference annotations to evaluate their effect on allele-specific transcript usage detection. This work provides a critical step toward improving transcriptome annotation across diverse populations, ensuring a more comprehensive representation of human genetic variation.

2025-03-13 | E-MTAB-14935 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data